Analytics, not advice. Rankings and scores describe past performance and are not recommendations.

Index Fund

Motilal Oswal Nifty MidSmall Healthcare Index Fund- Direct Plan-Growth

Motilal Oswal Mutual Fund · Managed by Swapnil Mayekar; Rakesh Shetty; Dishant Mehta

Ask about this fund
FundScore
Latest NAV
₹12.7208
as of 07 Aug 2026
AUM
—
Expense ratio
0.71%
as of 30 Jun 2026
Inception
14 May 2026
FundScore
54/100steady
Rank #579 of 1325 in Index Fund · top 46%

A daily percentile of this fund’s past performance within its SEBI category — analytics, not advice, and not a prediction or recommendation.

Trailing returns
Annualised returns to the latest NAV. Refreshed nightly.
1M
5.64%
3M
10.46%
6M
27.01%
1Y
18.82%
3Y CAGR
—
5Y CAGR
—
Since incep.
14.06%
Fund details
Fund manager
Swapnil Mayekar; Rakesh Shetty; Dishant Mehta
Riskometer
Very High Risk
Type
Open Ended
Portfolio turnover
38%
Volatility (3Y)
16.5%
Rating (external)
—
Investment objective

The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by Nifty MidSmall Healthcare Total Return Index, subject to tracking error.

NAV history
Zoom and pan · ranges from 1M to since-inception.
Rolling returns
Every 30-day step. The true distribution, not cherry-picked.
Rank history
Percentile within category over the last 2 years.
FundScore components
Pro-only breakdown of consistency, recency, and volatility scores.

Upgrade to Pro to see the raw drivers behind this scheme's FundScore label.

Pro
Market-cap distribution
Large / mid / small / micro-cap split of this fund's equity holdings, from its latest look-through portfolio. Shown as a share of classified equity.
Mid cap65.4%
Small cap34.6%
Stock holdings
Latest portfolio disclosure for this scheme. Snapshot as of 30 Apr 2026.
Lupin Limited
equity
9.88%
Fortis Healthcare Limited
equity
8.50%
Laurus Labs Limited
equity
7.57%
Aurobindo Pharma Limited
equity
6.87%
Glenmark Pharmaceuticals Limited
equity
6.40%
Alkem Laboratories Limited
equity
5.58%
Biocon Limited
equity
4.54%
Mankind Pharma Limited
equity
4.49%
IPCA Laboratories Limited
equity
3.76%
Aster DM Healthcare Limited
equity
3.14%
J B Chemicals and Pharma Ltd
equity
2.95%
Krishna Institute Of Medical Sciences Limited
equity
2.91%
Sai Life Sciences Limited
equity
2.60%
Gland Pharma Limited
equity
2.46%
Abbott India Limited
equity
2.32%
Neuland Laboratories Limited
equity
2.28%
Narayana Hrudayalaya Limited
equity
2.16%
Ajanta Pharma Limited
equity
2.10%
Wockhardt Limited
equity
2.04%
Dr. Lal Path Labs Limited
equity
1.88%
Granules India Limited
equity
1.79%
Piramal Pharma Limited
equity
1.77%
Natco Pharma Limited
equity
1.74%
GlaxoSmithKline Pharmaceuticals Limited
equity
1.71%
Onesource Specialty Pharma Limited
equity
1.69%
Global Health Limited
equity
1.67%
Syngene International Limited
equity
1.57%
Cohance Lifesciences Limited
equity
1.39%
Pfizer Limited
equity
1.26%
Poly Medicure Limited
equity
1.02%